Effect of Variant Alleles SLCO1B1 and ABCG2 on Pharmacokinetics of Rosuvastatin in Healthy Volunteers.
Phase of Trial: Phase IV
Latest Information Update: 22 Apr 2016
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Cardiovascular disorders; Hypercholesterolaemia; Hyperlipidaemia; Hypertriglyceridaemia
- Focus Pharmacogenomic; Pharmacokinetics
- 21 May 2012 Planned End Date changed from 30 Dec 2010 to 31 Mar 2011 as reported by Chinese Clinical Trial Register record.
- 19 Nov 2010 New trial record